BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8833122)

  • 1. Foveal color and luminance sensitivity losses in glaucoma.
    Kelly JP; Fourman SM; Jindra LF
    Ophthalmic Surg Lasers; 1996 Mar; 27(3):179-87. PubMed ID: 8833122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foveal and non-foveal measures of short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Ophthalmic Physiol Opt; 1987; 7(4):403-4. PubMed ID: 3454916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of color pattern reversal visual evoked potential of primary glaucoma].
    Wang PB; Tong Y; Xia ZH; Tan Q; Xia XB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):821-5. PubMed ID: 18812661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatic modulation of luminance visual evoked potential latencies in healthy subjects and patients with mild vision disorders.
    Accornero N; Gregori B; Pro S; Scappini G; La Riccia M
    Clin Neurophysiol; 2008 Jul; 119(7):1683-8. PubMed ID: 18455475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse field loss and central visual function in glaucoma.
    Lachenmayr BJ; Drance SM
    Ger J Ophthalmol; 1992; 1(2):67-73. PubMed ID: 1477628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red-green chromatic mechanisms in normal aging and glaucomatous observers.
    Karwatsky P; Overbury O; Faubert J
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2861-6. PubMed ID: 15277514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent substitution stimulation of S-cone pathway and L- and M-cone pathway in glaucoma.
    Bessler P; Klee S; Kellner U; Haueisen J
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):319-26. PubMed ID: 19710415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Luminance contrast and color contrast evoked pattern electroretinogram in normal eyes and in eyes with glaucoma].
    Korth M; Horn F
    Fortschr Ophthalmol; 1990; 87(4):403-8. PubMed ID: 2210573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
    Silverman SE; Hart WM; Gordon MO; Kilo C
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived color of hallucinations in the Charles Bonnet Syndrome is related to residual color contrast sensitivity.
    Madill SA; Lascaratos G; Arden GB; ffytche DH
    J Neuroophthalmol; 2009 Sep; 29(3):192-6. PubMed ID: 19726940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in colour vision parameters following successful trabeculectomy.
    Magacho L; Henderer JD; Lankaranian D; Steinmann WC; Spaeth GL
    Acta Ophthalmol Scand; 2006 Apr; 84(2):201-5. PubMed ID: 16637837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonselective losses in foveal chromatic and luminance sensitivity in multiple sclerosis.
    Foster DH; Snelgar RS; Heron JR
    Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1431-41. PubMed ID: 4044171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of the color perceptive space in protanomals].
    Vartanov AV; Polianskiĭ VB; Sokolov EN; Evtikhin DV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(5):788-96. PubMed ID: 9949528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central visual fields for short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Invest Ophthalmol Vis Sci; 1988 Jan; 29(1):64-72. PubMed ID: 3335434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glaucoma on central visual function.
    Stamper RL
    Trans Am Ophthalmol Soc; 1984; 82():792-826. PubMed ID: 6398938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blue-sensitive VEP test in diagnosis of glaucoma].
    Korth M; Nguyen NX; Jünemann A; Martus P
    Klin Monbl Augenheilkd; 1993 Nov; 203(5):324-8. PubMed ID: 8114474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease.
    Grigsby SS; Vingrys AJ; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3252-62. PubMed ID: 1748555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color vision deficit in normal-tension glaucoma eyes.
    Yamagami J; Koseki N; Araie M
    Jpn J Ophthalmol; 1995; 39(4):384-9. PubMed ID: 8926646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.